GDF2 and hereditary hemorrhagic telangiectasia: Previous studies have measured BMP9 and pBMP10 plasma levels along with the serum-derived endothelial BMP activity in patients with homozygous nonsense GDF2 mutations, PAH patient and a patient with “HHT-like” phenotype.